FDA and NABP Partnership: Information-Sharing for Drug Compounding

The Food and Drug Administration (FDA) recently announced that it awarded a cooperative grant to the National Association of Boards of Pharmacy (NABP) to create an information-sharing data system to improve the information available to state regulators and the FDA about state-licensed pharmacies that engage in interstate distribution of compounded drugs.

The new data system will focus on the collection, management and sharing of compounding pharmacy information in the United States and will provide the state boards of pharmacy with a tool to report and share interstate compounding pharmacy information with other boards of pharmacy and the FDA. The pooled information will then enable boards of pharmacy and the FDA to provide more targeted regulation and oversight of compounded drugs, while also focusing on patient safety.